• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
The Politics of Pharma: Washington, States, and the Court's Impact on the Industry Product Image

The Politics of Pharma: Washington, States, and the Court's Impact on the Industry

  • ID: 2517218
  • April 2013
  • Region: Global
  • 49 Pages
  • CBR Pharma Insights

Politics have a greater direct effect on the pharmaceutical industry than almost any other in the US, and correspondingly, pharma makes considerable investments in election campaigns. The November elections kept the face of Washington the same, with the re-election of President Obama, Democratic control of the Senate and Republican control of the House. However, the outcome of the elections will still impact the industry in a variety of ways.

The Medical Device Excise Tax, a component of the 2010 health care reform legislation, survived a pre-election Congressional effort at repeal, but a coalition of House Republicans and Democrats from key states are looking to try again. Post-election, another bi-partisan congressional group is pushing for the FDA to impose stricter regulations on certain painkillers. Meanwhile, the Administration’s prioritization of generics at the FDA remains controversial.

The budget impasse and resulting sequestration are election fall-outs that may impact the pharmaceutical industry in a number of ways: decreased vaccine sales, reduced research funding and potential cuts at the FDA that could dramatically raise time to market. Medicare reform READ MORE >

Executive Summary

Chapter 1: November Election Results
- Pharma’s investment in the elections
- Election results
- Medical device tax
- Congressional spotlight on painkillers
- The FDA

Chapter 2: Health Care Reform
- Implementation
- The Sunshine Act
- Meaningful use debate

Chapter 3: State Politics
- State Health Care Exchanges
- Biosimilar substitution

Chapter 4: The Courts
- Pay-for-delay
- Generics liability
- Reform
- Off-label use

Chapter 5: The Political Outlook
- Impact of the budget impasse
- Medicare
- Indian trade issues
- The CBR View

Appendix

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos